Sphera Funds Management »

Nuvectis Pharma shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.0M 383k 18.39

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Biogen Idec (BIIB)
Mineralys Therapeutics (MLYS)
Tower Semiconductor Shs New (TSEM)
Cytokinetics Com New (CYTK)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Syndax Pharmaceuticals (SNDX)
Ultragenyx Pharmaceutical (RARE)
BioMarin Pharmaceutical (BMRN)
Bridgebio Pharma (BBIO)
Cogent Biosciences (COGT)
NOVA MEASURING Instruments L (NVMI)
Insmed Com Par $.01 (INSM)
Maze Therapeatics (MAZE)
Astrazeneca Ord (AZN)

View all positions for Sphera Funds Management

Top funds holding Nuvectis Pharma

Tang Capital Management
BlackRock
Soleus Capital Management
Perceptive Advisors
Vanguard Capital Management
Iridian Asset Management
Geode Capital Management
Sphera Funds Management
Baldwin Brothers
Occam Crest Management
Susquehanna International
Alyeska Investment Group
Avidity Partners Management
Citadel Advisors
State Street Corporation

View all funds holding Nuvectis Pharma